Teijin Limited, a Japanese chemical and technology-driven global group, posted 16.5 per cent net sales decline to ¥179.1 billion (Japan Yen) in its first quarter (Q1) fiscal 2020 ended on June 30, compared to the sales of ¥214.6 billion in the same period last year. Group’s profit for the quarter slipped to ¥6.2 billion (Q1 FY19: ¥11.0 billion).
Gross profit for Q1 FY20 was down to ¥59.6 billion (¥67.6 billion). Selling, general and administrative expenses for the period were ¥47.0 billion (¥50.7 billion). Operating income for the quarter dropped 25.8 per cent to ¥12.5 billion (¥16.9 billion). Whereas, ordinary income was ¥12.4 billion (¥16.8 billion).
Sales of Materials segment were ¥56.1 billion (¥89.4 billion). Healthcare segment sales were ¥36.1 billion (¥39.8 billion). Fibres & products converting segment sales dropped marginally to ¥72.3 billion (¥75.0 billion).